Drug interactions
Cell 178:316329.e18 Maj T, Wang W, Crespo J, Zhang H, Wang W, Wei S, Zhao L, Vatan L, Shao I, Szeliga W, Lyssiotis C, Liu JR, Kryczek I, Zou W (2017) Oxidative stress controls regulatory T cell apoptosis and suppressor activity and PD-L1-blockade resistance in tumor
Semaglutide and Tirzepatide are both FDA-approved and have undergone extensive clinical trials
A meta-analysis comparing the two compounds directly found retatrutide produced an average of 16.34 kg of weight loss compared to 11.82 kg for tirzepatide
GHRH itself was characterized in the early 1980s, isolated originally from pancreatic tumors in patients with acromegaly and shown to consist of a 44-residue amidated peptide (and shorter active derivatives)